Pros: the present classification of mucinous adenocarcinomas of the lung.
作者信息
Dacic Sanja
机构信息
Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
出版信息
Transl Lung Cancer Res. 2017 Apr;6(2):230-233. doi: 10.21037/tlcr.2017.04.11.
Abstract
摘要
相似文献
1
Pros: the present classification of mucinous adenocarcinomas of the lung.优点：目前肺黏液腺癌的分类
Transl Lung Cancer Res. 2017 Apr;6(2):230-233. doi: 10.21037/tlcr.2017.04.11.
2
KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung.肺浸润性黏液腺癌中的 KRAS 和 NKX2-1 突变。
J Thorac Oncol. 2016 Apr;11(4):496-503. doi: 10.1016/j.jtho.2016.01.010. Epub 2016 Jan 30.
3
Comparative Characteristics of Napsin A, TTF 1 and EGFR Mutation Expression in Mucinous Lung Cell Carcinomas.黏液性肺细胞癌中Napsin A、TTF 1和EGFR突变表达的比较特征
Folia Med (Plovdiv). 2017 Jun 1;59(2):174-182. doi: 10.1515/folmed-2017-0020.
4
Napsin A expression in primary mucin-producing adenocarcinomas of the lung: an immunohistochemical study.Napsin A 在肺原发性黏液性产腺癌中的表达：免疫组织化学研究。
Am J Clin Pathol. 2013 Feb;139(2):160-6. doi: 10.1309/AJCP62WJUAMSZCOM.
5
Mucinous bronchioloalveolar carcinomas display a specific pattern of mucin gene expression among primary lung adenocarcinomas.黏液性细支气管肺泡癌在原发性肺腺癌中表现出特定的黏蛋白基因表达模式。
Hum Pathol. 2001 Mar;32(3):274-81. doi: 10.1053/hupa.2001.22752.
6
Mucinous differentiation correlates with absence of EGFR mutation and presence of KRAS mutation in lung adenocarcinomas with bronchioloalveolar features.在具有细支气管肺泡特征的肺腺癌中，黏液分化与表皮生长因子受体（EGFR）突变缺失及KRAS突变存在相关。
J Mol Diagn. 2007 Jul;9(3):320-6. doi: 10.2353/jmoldx.2007.060182.
7
Napsin-A, TTF-1, EGFR, and ALK Status Determination in Lung Primary and Metastatic Mucin-Producing Adenocarcinomas.肺原发性和转移性黏液腺癌中Napsin-A、甲状腺转录因子-1、表皮生长因子受体和间变性淋巴瘤激酶状态的测定
Int J Surg Pathol. 2014 Aug;22(5):401-7. doi: 10.1177/1066896914527609. Epub 2014 Mar 19.
8
[Relevance of molecular alterations in histopathologic subtyping of lung adenocarcinoma based on 2011 International Multidisciplinary Lung Adenocarcinoma Classification].基于2011年国际多学科肺腺癌分类的分子改变在肺腺癌组织病理学亚型中的相关性
Zhonghua Bing Li Xue Za Zhi. 2012 Aug;41(8):505-10. doi: 10.3760/cma.j.issn.0529-5807.2012.08.001.
9
Genomic Characteristics of Invasive Mucinous Adenocarcinomas of the Lung and Potential Therapeutic Targets of B7-H3.肺侵袭性黏液腺癌的基因组特征及B7-H3的潜在治疗靶点
Cancers (Basel). 2018 Nov 30;10(12):478. doi: 10.3390/cancers10120478.
10
Histology and oncogenic driver alterations of lung adenocarcinoma in Chinese.中国肺腺癌的组织学与致癌驱动因素改变
Am J Cancer Res. 2019 Jun 1;9(6):1212-1223. eCollection 2019.
引用本文的文献
1
Concomitance of Pericardial Tamponade and Pulmonary Embolism in an Invasive Mucinous Lung Adenocarcinoma with Atypical Presentation: Diagnostic and Therapeutic Pitfalls-Case Report and Literature Review.侵袭性黏液性腺癌表现不典型伴发心包填塞和肺栓塞：诊断和治疗陷阱——病例报告及文献复习。
Int J Mol Sci. 2024 Aug 1;25(15):8413. doi: 10.3390/ijms25158413.
2
Efficacy of Touch Imprint Cytology in Intraoperative Diagnosis of Invasive Mucinous Adenocarcinoma of the Lung: A Case Report and Literature Review.触摸印片细胞学在肺浸润性黏液腺癌术中诊断中的应用效果：1例病例报告及文献复习
Clin Pract. 2024 Jan 29;14(1):242-249. doi: 10.3390/clinpract14010019.
3
Morphologically intact airways in lung fibrosis have an abnormal proteome.肺纤维化中形态完整的气道具有异常的蛋白质组。
Respir Res. 2023 Apr 1;24(1):99. doi: 10.1186/s12931-023-02400-x.
4
Postoperative survival of pulmonary invasive mucinous adenocarcinoma versus non-mucinous invasive adenocarcinoma.肺浸润性黏液腺癌与非黏液性浸润性腺癌的术后生存比较。
BMC Pulm Med. 2023 Jan 9;23(1):9. doi: 10.1186/s12890-023-02305-x.
5
Prognosis of resected invasive mucinous adenocarcinoma compared with the IASLC histologic grading system for invasive nonmucinous adenocarcinoma: Surgical database study in the TKIs era in Korea.韩国 TKI 时代的外科数据库研究：与 IASLC 浸润性非黏液性腺癌组织学分级系统相比，切除的浸润性黏液性腺癌的预后。
Thorac Cancer. 2022 Dec;13(23):3310-3321. doi: 10.1111/1759-7714.14687. Epub 2022 Nov 7.
6
CT Features of Stage IA Invasive Mucinous Adenocarcinoma of the Lung and Establishment of a Prediction Model.肺IA期浸润性黏液腺癌的CT特征及预测模型的建立
Int J Gen Med. 2022 Jun 4;15:5455-5463. doi: 10.2147/IJGM.S368344. eCollection 2022.
7
Clinical features and prognosis of resectable pulmonary primary invasive mucinous adenocarcinoma.可切除性肺原发性浸润性黏液腺癌的临床特征及预后
Transl Lung Cancer Res. 2022 Mar;11(3):420-431. doi: 10.21037/tlcr-22-190.
8
Radiological and clinical features of screening-detected pulmonary invasive mucinous adenocarcinoma.筛查检出的肺浸润性黏液腺癌的放射学和临床特征。
Interact Cardiovasc Thorac Surg. 2022 Jan 18;34(2):229-235. doi: 10.1093/icvts/ivab257.
9
Development and validation of a nomogram for predicting survival of pulmonary invasive mucinous adenocarcinoma based on surveillance, epidemiology, and end results (SEER) database.基于监测、流行病学和最终结果（SEER）数据库开发和验证预测肺浸润性黏液性腺癌生存的列线图。
BMC Cancer. 2021 Feb 10;21(1):148. doi: 10.1186/s12885-021-07811-x.
10
The Underlying Tumor Genomics of Predominant Histologic Subtypes in Lung Adenocarcinoma.肺腺癌主要组织学亚型的潜在肿瘤基因组学。
J Thorac Oncol. 2020 Dec;15(12):1844-1856. doi: 10.1016/j.jtho.2020.08.005. Epub 2020 Aug 10.
本文引用的文献
1
KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung.肺浸润性黏液腺癌中的 KRAS 和 NKX2-1 突变。
J Thorac Oncol. 2016 Apr;11(4):496-503. doi: 10.1016/j.jtho.2016.01.010. Epub 2016 Jan 30.
2
Unique Genetic and Survival Characteristics of Invasive Mucinous Adenocarcinoma of the Lung.肺浸润性黏液腺癌的独特遗传和生存特征。
J Thorac Oncol. 2015 Aug;10(8):1156-62. doi: 10.1097/JTO.0000000000000579.
3
Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities.同时发生的基因组改变定义了具有不同生物学特性、免疫特征和治疗易感性的KRAS突变型肺腺癌的主要亚组。
Cancer Discov. 2015 Aug;5(8):860-77. doi: 10.1158/2159-8290.CD-14-1236. Epub 2015 Jun 11.
4
An update on clinicopathological, immunohistochemical, and molecular profiles of colloid carcinoma of the lung.肺黏液腺癌的临床病理、免疫组化及分子特征的最新进展
Hum Pathol. 2015 Jun;46(6):836-42. doi: 10.1016/j.humpath.2014.10.032. Epub 2015 Feb 20.
5
Transcriptome meta-analysis of lung cancer reveals recurrent aberrations in NRG1 and Hippo pathway genes.肺癌的转录组荟萃分析揭示了NRG1和Hippo信号通路基因的反复畸变。
Nat Commun. 2014 Dec 22;5:5893. doi: 10.1038/ncomms6893.
6
Associations between mutations and histologic patterns of mucin in lung adenocarcinoma: invasive mucinous pattern and extracellular mucin are associated with KRAS mutation.肺腺癌中黏蛋白突变与组织学模式之间的关联：浸润性黏液模式和细胞外黏蛋白与KRAS突变相关。
Am J Surg Pathol. 2014 Aug;38(8):1118-27. doi: 10.1097/PAS.0000000000000246.
7
Druggable oncogene fusions in invasive mucinous lung adenocarcinoma.浸润性黏液性肺腺癌中的可靶向致癌基因融合
Clin Cancer Res. 2014 Jun 15;20(12):3087-93. doi: 10.1158/1078-0432.CCR-14-0107. Epub 2014 Apr 11.
8
Non-terminal respiratory unit type lung adenocarcinoma has three distinct subtypes and is associated with poor prognosis.非小细胞肺癌中的肺腺泡型具有三个不同亚型，与不良预后相关。
Lung Cancer. 2014 Jun;84(3):281-8. doi: 10.1016/j.lungcan.2014.03.013. Epub 2014 Mar 27.
9
CD74-NRG1 fusions in lung adenocarcinoma.肺腺癌中的 CD74-NRG1 融合。
Cancer Discov. 2014 Apr;4(4):415-22. doi: 10.1158/2159-8290.CD-13-0633. Epub 2014 Jan 27.
10
International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.国际肺癌研究协会/美国胸科学会/欧洲呼吸学会国际多学科肺腺癌分类。
J Thorac Oncol. 2011 Feb;6(2):244-85. doi: 10.1097/JTO.0b013e318206a221.
Zotero 插件